MedPath

Respiratory Mechanics and Gas Exchange Characteristics in Patient With SARS-CoV-2

Conditions
Covid19
ARDS, Human
Registration Number
NCT04486729
Lead Sponsor
Sanatorio Anchorena San Martin
Brief Summary

The combination of different ventilatory strategies and its effects on respiratory mechanics and gas exchange in patients under mechanical ventilation with acute respiratory distress syndrome secondary to coronavirus-19 has been scarcely described.

Detailed Description

Investigation in mechanically ventilated patients with with acute respiratory distress syndrome (ARDS) secondary to coronavirus-19 (COVID-19) is emerging due to presumed differences with typical ARDS from other origin. Considering these issues, the effects of ventilatory strategies such as positive end expiratory pressure, end inspiratory pause and fraction of inspired oxygen on respiratory mechanics and gas exchange must be studied in order to characterize the behavior of COVID-19 ARDS during invasive mechanical ventilation and choose the best combination of ventilatory settings.

In this study the investigators will evaluate the changes in respiratory mechanics and gas exchange produced by low and high positive end expiratory pressure, low and high inspired oxygen fraction and the application of end inspiratory pause during volume controlled mechanical ventilation.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
15
Inclusion Criteria
  • Older than 18 years old
  • less than 72 hs since ARDS diagnosis
  • Moderate to severe ARDS
  • central venous catheter and arterial line available
  • Need of neuromuscular blocking agents
  • Supine position
  • Informed consent accepted
  • Airway opening pressure lower than 20 cmH2O
Exclusion Criteria
  • RASS target higher than -5
  • COPD diagnosis
  • Pneumothorax
  • Intracraneal Hypertension
  • Pregnancy
  • Cardiac inssuficiency uncompensated
  • Chest wall deformity
  • Bronchopleural fistula
  • Contraindication to use esophageal manometry

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Driving transpulmonary pressure (cmH2O)10 minutes

The driving transpulmonary pressure will be evaluated between the high and low PEEP condition using the formula: driving transpulmonary pressure = driving airway pressure - driving esophageal pressure (cmH2O).

Bohr dead space fraction (%)10 minutes

The Bohr dead space fraction will be evaluated with high PEEP between the condition with end inspiratory pause and with no end inspiratory pause application using the formula: Bohr dead space fraction = Alveolar pressure of CO2 (PACO2) - Expired pressure of CO2 (PECO2) / PACO2

Shunt fraction (%)10 minutes

The shunt fraction will be evaluated with low PEEP between the condition with high fraction of oxygen to achieve a saturation goal of 96-98% and the condition with low fraction of oxygen to achieve a saturation goal of 88-92%. The shunt fraction will be calculated using the formula: Qs/Qt = (capillary oxygen content - arterial oxygen content)/(capillary oxygen content - venous oxygen content)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Sanatorio Anchorena San Martin

🇦🇷

San Martin, Buenos Aires, Argentina

© Copyright 2025. All Rights Reserved by MedPath